American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

AHPA joins leading health and food organizations to urge lawmakers to clearly define exemptions to shelter-in-place orders

Three letters urge clear definition of employee exemptions for shelter-in-place orders

In a series of three letters to federal, state, and local governments, AHPA joined healthcare and food organizations to request that uniform language be included in shelter-at-home orders that provide direction to employees working in various industries related to dietary supplements, healthcare, and pharmaceuticals.

AHPA COVID-19 Information & Resources Web Center

Answers to FAQs regarding COVID-19 impact on dietary supplements and food

AHPA has compiled answers to frequently asked questions and resources to help prepare for and respond to COVID-19. This page will be revised and updated regularly as new information about the novel coronavirus (SARS-CoV-2) and possible impacts on the herbal products industry and the people who work in this trade becomes available.

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

For 10 years AHPA’s Cannabis Committee has been actively involved in the regulatory, legislative, and technical aspects of moving cannabis (including hemp-CBD) into the legal marketplace

Silver Spring, MD – The American Herbal Products Association (AHPA), the voice of the herbal products industry, celebrates the 10-year anniversary of its Cannabis Committee today. The Committee was established on March 10, 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including hemp and hemp-derived cannabidiol (CBD).
Adverse Event Reporting Tells the Story of Dietary Supplement Safety

Adverse Event Reporting Tells the Story of Dietary Supplement Safety

FDA AER data often lacks fields that may prevent misinterpretation, including FDA’s assessment of causation

Washington, D.C. — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data. Dr. Kingston is an expert on clinical toxicology and pharmacology, poison control, product post-market surveillance, and drug and dietary supplement safety.

February 2020 AHPA in the News


Industry Coalition Reminds Consumers, Retailers that Dietary Supplements May Not Claim to Cure, Prevent Coronavirus

Some marketers of dietary supplements or other products may be promoting them with claims of prevention or treatment of Coronavirus

The U.S. dietary supplement industry is aware of the growing concern regarding the Novel Coronavirus (2019-nCoV) and of the public’s desire to protect itself against the virus. The four leading trade associations representing the dietary supplement industry support the responsible sale and use of vitamins, minerals, herbs and other dietary supplements that provide many positive benefits promoting better health and wellness. However, we are concerned that some marketers of dietary supplements or other products may be promoting them with claims of prevention or treatment of Coronavirus.

January 2020 AHPA in the News


AHPA submits comments to USDA on domestic hemp production program

Significant room for improvement in the hemp production Interim Final Rule and the subsequent Final Rule

In comments submitted to U.S. Department of Agriculture (USDA), Agricultural Marketing Service (AMS), AHPA requested numerous, significant revisions to the Interim Final Rule (IFR) that establishes a domestic hemp production program before a Final Rule is promulgated in 2021.

“Phase One” agreement with China provides some relief to supplement importers

Reduced tariffs will affect imports filed after February 14

A partial trade agreement signed by the United States and China on January 15, 2020, will reduce U.S.-imposed tariffs on some imported Chinese goods used by U.S. dietary supplement and food companies, but it will leave tariffs on other commodities in place, at least for the short term.

December 2019 AHPA in the News


RSS
12345678910 Last

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.